Walleye Trading LLC Gritstone Bio, Inc. Transaction History

Walleye Trading LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$8.13 - $10.2 $216,314 - $271,391	-26,607 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.07 - $27.11 $60,069 - $400,116	-14,759 Reduced 35.68%	26,607 $251,000
Q4 2020 Feb 16, 2021	SELL	$2.57 - $4.22 $110,998 - $182,261	-43,190 Reduced 51.08%	41,366 $163,000
Q3 2020 Nov 16, 2020	BUY	$2.63 - $8.09 $222,382 - $684,058	84,556 New	84,556 $224,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.